Mark Davison Email & Phone Number

Shepreth, Cambridgeshire, Gb

Award-winning CEO of Grant Instruments, responsible for 70+ staff in the UK, USA and India. One of LDC Top 50 Most Ambitious Business Leaders 2023.We design, manufacture and sell scientific instruments for precision cryopreservation, general lab activities, and measuring and logging of data. We also provide hardware, software and services. As well as being leaders in cryopreservation with our revolutionary CRFT device, we are still the pre-eminent brand of scientific water baths, which was our original product almost 70 years ago. Many of the world's major universities and corporations work with Grant, as do many prestigious and accuracy-driven organisations like CERN and NASA.My team has implemented leading-edge employment practices including a permanent four-day week cycle for all employees. Culture is at the heart of what makes us excellent, and I spend a lot of my time working with my management colleagues to develop and embed our values. We also focus on sustainability throughout our business, committing to carbon zero by 2040. We have an active supplier support programme to help estimate and reduce our Scope 3 emissions. We are also planting a tree for every order we receive (via Ecologi) to offset the emissions that we can't eliminate. I work with colleagues, customers and suppliers to make our products and services as good as they can be. We have a seventy-year heritage, and we are known for reliability and service, but we set out to re-earn that reputation every day.

https://thebigexperiment.buzzsprout.com/Interviewing tech founders and CEOs, to discover how great science becomes big business. Every two weeks on your usual podcast channels. If you know someone whose founder story needs to be heard, message me!

Reno, Nevada, Us

Responsible for global sales growth of rfxcel (now part of Antares Vision) outside USA. Territories included:EMEA - Set up and managed regional entity in the UK, including responsibility for all legal, accounting banking and HR obligations as an employer. Recruited sales and operational staff, drove regulatory engagement with EMVO, and helped land the first home-grown deals. Grew sales substantially to provide SaaS applications to many large customers. Russia - starting from zero, recruited a General Director and helped set up local legal entity in Moscow. At that time it became the fastest growing region, with multiple hires and new business across several industry verticals. LatAm - Team based in Sao Paulo developed a great pipeline and we closed seven-figure SaaS deal.APAC - Closed a sales and support deal with CAC in Japan (www.cac.co.jp). Visiting and supporting CAC as they grew our joint business. Several other projects in the wider APAC region.Further expanded our capability and drove triple digit YOY growth in L4/L5 serialisation and blockchain customer base.

Cambridge, Cambridgeshire, Gb

Founder of Blue Sphere Health (Bluesphere). Provided strategic and tactical consulting services worldwide for pharma companies, healthcare providers and governments at Board level and below. Strategic insights around exploiting disruptive trends in traceable supply chains and patient engagement to generate commercial upsides. Tactical activities included the design, implementation and support of serialization, anti-counterfeiting, anti-diversion, authentication, patient safety, product protection, brand security initiatives. Expertise in broader supply chain and e-health areas such as cold chain, environmental monitoring, patient compliance / adherence, mobile medicine and new data-driven business models in healthcare.

New Delhi, Delhi, In

CBO and commercial adviser to PharmaSecure, based in India. Experts in track-and-trace of medicines.

Signed by Wiley to write the textbook on anti-counterfeiting, diversion, brand protection, supply chain security and related issues in the pharmaceutical industry. Available on Amazon as hard copy or Kindle format. "Pharmaceutical Anti-Counterfeiting: Combating the Real Danger from Fake Drugs":“Practical guides that are both well written and useful are, unfortunately, rare. So it is with pleasure that I recommend Pharmaceutical Anti-Counterfeiting: Combating the Real Danger from Fake Drugs by Mark Davison... it is a valuable insider’s handbook for professionals working in the fields of product security and brand protection.” Roger Bate, American Enterprise Institute

Lausanne, Ch

Drove the worldwide healthcare business of the leading security (anti-counterfeiting) technology and systems supplier. Experienced in leading business negotiations in Europe, Asia (including Japan and China), Africa, North America and South America. Very wide and deep knowledge of technical and regulatory aspects of product security, including serialisation, e-pedigree, authentication, tamper-evidence etc. Highly adept and experienced at discreet, senior-level business building - often at government minister or Board level.

Advised management team before and during the spin out of DDS, a clinical pharmacology company, from the University of Dundee. Sat on the board after spin-out as a commercial advisor and independent director (non-exec). The company was eventually sold to Chiltern.

London / New York based virtual product development company. In-license / out-license model. I was responsible for identifying, negotiating, signing and developing the Central Nervous System drugs portfolio for eventual outlicense. The company ran out of cash in difficult fundraising conditions.

Founded, ran and grew a business consultancy serving public sector and private sector customers, mainly in healthcare. Business planning, business development, interim management, mentoring, training etc. Profitable since inception and until I went back into a senior biopharma industry role.

Recruited to run a public sector-funded biotechnology alliance to promote bioscience in Scotland. Initiated and drove strategy and coordinated multiple public sector stakeholders and private sector sponsors. See:http://www.nature.com/naturejobs/2001/010329/full/nj0051.html

Durham, North Carolina, Us

Responsible for business development for clinical trials in cardiovascular area. My area was Quintiles' biggest clinical business group with deal size $1m - $50m. Subsequently Account Director for Quintiles biggest single clinical customer.

Wilmington, Massachusetts, Us

At the time I worked for Inveresk Research, subsequently acquired by Charles River. Business development for clinical trials - especially Phase I - and biologics safety testing. Extensive business experience in Europe and USA.

Brentford, Middlesex, Gb

Joined the anti-infectives group at Brockham Park in the Smithkline Beecham era. Started as a bench scientist in biochemistry and microbiology. Worked on natural product identification and on the biosynthetic enzyme pathway for clavulanic acid biosynthesis (beta-lactamase inhibitor and major component for blockbuster product Augmentin). Subsequently led research project on inhibition of protein secretion in bacteria.Chairman of SmithKline Beecham Social Club and occasional impressionist (voices, not paintings) at Christmas revues.

Bsc (Hons) 1St Class, Biochemistry

Other, Certificate In Disruptive Strategy

Education record